Blood lead testing, screening, screening-related services, and diagnostic evaluations as required by § 2602 of this title are reimbursable under health insurance contracts and group and blanket health insurance under §§ 3337 and 3554 of Title 18, respectively.
Del. Code tit. 16, § 2604
Reimbursement by third-party payers
Known as the Childhood Lead Poisoning Prevention Act
The act spans §§ 16–16 (16 sections).
69 Del
Official source: Delaware Code Online. Reproduced from public-domain Delaware statutes; confirm against the official source for the current text. Not legal advice.